Presagen has merged with Qubist to become Qubigen

Qubigen is an exciting new venture that merges Presagen’s Federated AI technology and Qubist’s virtual screening and AI drug design capability.

Qubigen’s mission is to create the largest global federated proprietary dataset and computational toolbox for AI driven drug design.

Qubigen - accelerate drug design without exposing secrets.

Whether you're advancing active programs, reviving dormant data, or starting from scratch, Qubigen’s secure AI platform and virtual screening capabilities can help you identify, optimize, and accelerate the path to promising lead drug candidates. Get in touch to explore how we can support your next discovery.

enquiries@qubigen.com.